TNFSF10 and breast carcinoma: Combined treatment with YM155 and TRAIL induced apoptosis and PARP cleavage in renal carcinoma cells (A498 and ACHN), breast carcinoma cells (MDA-MB231) and giloma cells (U251MG) (Figure 6A and 6B).